Elasmogen is a privately held drug discovery and development, biopharmaceutical company located in the thriving biologics cluster now established for over 15 years in Aberdeen, Scotland.  Elasmogen Ltd spun-out of the University of Aberdeen and the Scottish Biologics Facility in February 2016.




Elasmogen Ltd is backed by Deepbridge Capital LLP, the Scottish Investment Bank, Innovate UK and through access partnerships to its ground-breaking soloMER platform.